Uroflowmetry and Nocturnal Enuresis

N/AActive Not RecruitingNCT07028645

Furkan Adem Canbaz100 enrolled

Overview

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

A total of approximately 100 patients with enuresis will be evaluated retrospectively. Uroflowmetry parameters of these patients will be evaluated. For this purpose, patients will be divided to mainly three groups according to the treatment choices.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Enuresis, Nocturnal

Interventions

desmopressin melt form 120 μgDRUG

Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.

Desmopressin lyophilisate (Melt)DRUG

Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.

Propiverine tabletDRUG

Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg

Eligibility

Sex: ALLMin age: 5 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Presence of enuresis nocturna * Patients who have uroflowmetry test Exclusion Criteria: * Presence of lower urinary tract symptoms * Presence of anatomical or neurological problems * Patients with missing data

Locations (1)

Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital

Istanbul, Kadikoy, Turkey (Türkiye)

Outcomes

Primary Outcomes

Number of days without bedwetting

Achievement of bedwetting in one or less night of a month

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.